LON:CNSL Cambridge Nutritional Sciences (CNSL) Share Price, News & Analysis GBX 1.90 +0.18 (+10.21%) As of 11:12 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider TradesBuy This Stock About Cambridge Nutritional Sciences Stock (LON:CNSL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CNSL alerts:Sign Up Key Stats Today's Range 1.70▼ 1.9050-Day Range 1.70▼ 2.2052-Week Range 1.70▼ 4.33Volume158,424 shsAverage Volume206,126 shsMarket Capitalization£4.52 millionP/E Ratio3.17Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition. Read More Receive CNSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambridge Nutritional Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CNSL Stock News HeadlinesCambridge Nutritional Sciences Leadership Increases ShareholdingsNovember 19, 2025 | tipranks.comCambridge Nutritional Sciences Faces Historical Legal ChallengeJanuary 21, 2025 | tipranks.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.June 15 at 1:00 AM | Porter & Company (Ad)Cambridge Nutritional Sciences Resolves Legal Dispute with DHSCJanuary 16, 2025 | tipranks.comSee More Headlines CNSL Stock Analysis - Frequently Asked Questions How have CNSL shares performed this year? Cambridge Nutritional Sciences' stock was trading at GBX 1.94 at the start of the year. Since then, CNSL stock has decreased by 2.3% and is now trading at GBX 1.90. How were Cambridge Nutritional Sciences' earnings last quarter? Cambridge Nutritional Sciences plc (LON:CNSL) announced its quarterly earnings results on Monday, November, 10th. The company reported ($0.20) EPS for the quarter. Cambridge Nutritional Sciences had a net margin of 16.94% and a trailing twelve-month return on equity of 12.15%. How do I buy shares of Cambridge Nutritional Sciences? Shares of CNSL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings11/10/2025Today6/15/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Instruments & Supplies Sub-IndustryCommunication Current SymbolLON:CNSL CIKN/A Webwww.cnsplc.com Phone(217) 235-3311FaxN/AEmployees3,200Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 0.60 Trailing P/E Ratio3.17 Forward P/E Ratio51.54 P/E GrowthN/ANet Income-£3.03 million Net Margins16.94% Pretax MarginN/A Return on Equity12.15% Return on Assets-2.36% Debt Debt-to-Equity Ratio2.14 Current Ratio4.25 Quick RatioN/A Sales & Book Value Annual Sales£8.06 million Price / Sales0.56 Cash FlowN/A Price / Cash FlowN/A Book ValueGBX 4 per share Price / Book0.48Miscellaneous Outstanding Shares237,951,000Free FloatN/AMarket Cap£4.52 million OptionableN/A Beta2.10 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (LON:CNSL) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambridge Nutritional Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambridge Nutritional Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
